Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Chica and Heinz Schaller Foundation Honours DKFZ-Scientist

No. 03c | 22/01/2016 | by Koh

On January 27th, the Chica and Heinz Schaller Foundation will honour two outstanding young scientists based in Heidelberg. Edward Lemke and Hai-Kun Liu will each receive a prize money of 100,000 € for their research. With the 2015 prizes, the Foundation recognises Lemke’s and Liu’s excellent work in the field of biomedicine. At the German Cancer Research Center (DKFZ), Hai-Kun Liu is investigating stem cells of the central nervous system and their role in the development of brain tumours. Edward Lemke conducts research in structural biology at the European Molecular Biology Laboratory (EMBL) where he is developing new biological tools for manipulating biomolecules.

Hai-Kun Liu

Hai-Kun Liu is investigating how stem cells develop in the adult brain, with the goal of understanding how tumours develop. His work on the relationship between brain stem cells and brain tumour stem cells has yielded important results. He identified the Tlx protein as the key molecule in brain tumour stem cells. When the Tlx molecule was genetically switched off in mice, the tumour stem cells were unable to regenerate and the diseased animals survived longer. Tlx therefore holds much promise for new treatment strategies for glioblastoma, the most aggressive type of brain tumour. Liu and his associates also succeeded in tracking the genetic lineage of brain tumour stem cells in the living organism.

Hai-Kun Liu (b. 1978) studied biology at the Shandong Normal University in China and earned his doctorate at the Shanghai Institute for Biological Sciences of the Chinese Academy of Sciences. Dr. Liu worked as a postdoc at the DKFZ from 2005 to 2010. He has led the Helmholtz Young Investigator Group since 2011 and the research division of Molecular Neurogenetics since 2015. His department is associated with the DKFZ-ZMBH Alliance, strategically linking the two institutions. His laboratory is also part of the university’s Interdisciplinary Center for Neurosciences. The European Research Council has been funding Kai-Kun Liu since 2015 with an ERC Consolidator Grant.

Using methods of high-resolution fluorescence microscopy, Edward Lemke’s research group is investigating proteins that are not completely folded, i.e. “intrinsically unstructured”. The researchers aim to discover how such proteins can form a barrier that protects the cell nucleus. They are also exploring how HI and hepatitis B viruses circumvent this protection in order to introduce their own genetic material. To pursue its work, Lemke’s team is developing innovative precision tools from chemical biology that can make the mechanisms directly visible at the molecular level in nano resolution without interfering with the function of the living cells.

Edward Lemke (b. 1978) studied physical chemistry at the Technical University of Berlin and the University of Oklahoma in Norman, Oklahoma. He completed his dissertation in biophysics at the Max Planck Institute for Biophysical Chemistry in Göttingen. Lemke did postdoctoral research at the Scripps Research Institute in La Jolla, California, focusing on single-molecule fluorescence techniques and chemical biology. In 2009, he headed the Emmy Noether Independent Junior Research Group at EMBL. In 2015, he received an ERC Consolidator Grant from the European Research Council. Lemke works in close collaboration with researchers at Heidelberg University.

The Foundation was established in the year 2000 by two renowned molecular biologists, Chica Schaller and Heinz Schaller after whom the awards are named. The Foundation’s fundamental purpose is the support of biomedical research in Heidelberg. The funding it offers is flexible and free from bureaucratic constraints frequently encountered in academia. In addition to this Research Award of 100,000 €, presented annually since 2005, the Foundation has funded an endowed professorship as well as a number of long- and short-term fellowships for scientists transitioning to independent status. It is currently financing five Schaller Research Groups working at Heidelberg University and DKFZ.

At the awards ceremony, Edward Lemke and Hai-Kun Liu will briefly present their work in English. EMBL General Director Iain Mattaj will laud Lemke while Hannah Monyer, who directs the Department of Clinical Neurobiology at the DKFZ and Heidelberg University Hospital, will similarly honour Hai-Hun Liu. Heinrich Betz, a member of the Foundation’s board, will serve as moderator and Rohini Kuner, the first Research Awardee and also a board member, will present the certificates and prizes. The event will be held on January 27, 2016, at 4:00 PM in the Ute Greenier Hall (7th floor) of the BioQuant Centre, Im Neuenheimer Feld 267. The public is invited to attend.

Internet information:
Chica and Heinz Schaller Foundation –
Edward Lemke –
Hai-Kun Liu –

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS